Walmart to replace Astrazeneca on Nasdaq-100

0
131
Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here